Prolight Diagnostics (PRLD) Stock Overview
Develops diagnostic systems used in point of care testing in Sweden. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
PRLD Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Prolight Diagnostics AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 0.24 |
| 52 Week High | SEK 0 |
| 52 Week Low | SEK 0 |
| Beta | 2.73 |
| 1 Month Change | 19.12% |
| 3 Month Change | -36.05% |
| 1 Year Change | -23.10% |
| 3 Year Change | -48.73% |
| 5 Year Change | -90.65% |
| Change since IPO | -34.15% |
Recent News & Updates
Recent updates
Is Prolight Diagnostics (NGM:PRLD) In A Good Position To Invest In Growth?
Jul 14
Companies Like Prolight Diagnostics (NGM:PRLD) Can Afford To Invest In Growth
Nov 07We Think Prolight Diagnostics (NGM:PRLD) Can Easily Afford To Drive Business Growth
Jul 06Companies Like Prolight Diagnostics (NGM:PRLD) Are In A Position To Invest In Growth
Mar 09Prolight Diagnostics (NGM:PRLD) Is In A Good Position To Deliver On Growth Plans
Nov 24Shareholder Returns
| PRLD | SE Medical Equipment | SE Market | |
|---|---|---|---|
| 7D | -4.3% | 1.2% | 1.9% |
| 1Y | -23.1% | -10.3% | -1.6% |
Return vs Industry: PRLD underperformed the Swedish Medical Equipment industry which returned -12.5% over the past year.
Return vs Market: PRLD underperformed the Swedish Market which returned -4.1% over the past year.
Price Volatility
| PRLD volatility | |
|---|---|
| PRLD Average Weekly Movement | 14.8% |
| Medical Equipment Industry Average Movement | 8.5% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in SE Market | 13.5% |
| 10% least volatile stocks in SE Market | 3.4% |
Stable Share Price: PRLD's share price has been volatile over the past 3 months compared to the Swedish market.
Volatility Over Time: PRLD's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of Swedish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 16 | Ulf Bladin | prolightdx.com |
Prolight Diagnostics AB (publ) develops diagnostic systems used in point of care testing in Sweden. It engages in the development of PLD micro flex and flex membrane. Prolight Diagnostics AB (publ) was incorporated in 1999 and is based in Stockholm, Sweden.
Prolight Diagnostics AB (publ) Fundamentals Summary
| PRLD fundamental statistics | |
|---|---|
| Market cap | SEK 174.12m |
| Earnings (TTM) | -SEK 28.95m |
| Revenue (TTM) | SEK 37.40m |
Is PRLD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PRLD income statement (TTM) | |
|---|---|
| Revenue | SEK 37.40m |
| Cost of Revenue | SEK 0 |
| Gross Profit | SEK 37.40m |
| Other Expenses | SEK 66.35m |
| Earnings | -SEK 28.95m |
Last Reported Earnings
Mar 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.041 |
| Gross Margin | 100.00% |
| Net Profit Margin | -77.39% |
| Debt/Equity Ratio | 0% |
How did PRLD perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/07/23 18:36 |
| End of Day Share Price | 2025/07/23 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Prolight Diagnostics AB (publ) is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.